One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for ...
If you ever find a personal or work task daunting, you might just need to rethink how you approach it. Pomodoro apps and ...
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva’s anti-IL-15 candidate, TEV-‘408 ...
Real-time index price for Nasdaq Computer Index (IXCO), along with buy or sell indicators, analysis, charts, historical performance, news and more ...